Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Brand Names
Menactra
Generic Name
Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen
DrugBank Accession Number
DB10800
Background

Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen is an active intramuscular immunization for the prophylaxis of invasive meningococcal disease caused by Neisseria meningitidis serogroup W-135. The vaccine contains* N. meningitis* serogroup y capsular polysaccharide antigens that are purified and individually conjugated to diphtheria toxoid protein that are extracted from Corynebacterium diphtheriae grown in another culture.

Type
Biotech
Groups
Approved
Biologic Classification
Vaccines
Toxoid
Synonyms
  • Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine

Pharmacology

Indication

Not Available

Pharmacology
Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Contraindications & Blackbox Warnings
Contraindications
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Adverseeffects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Products2
Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
MenactraNeisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen (4 ug/0.5mL) + Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen (4 ug/0.5mL) + Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen (4 ug/0.5mL) + Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen (4 ug/0.5mL)Injection, solutionIntramuscularSanofi Pasteur Inc.2005-01-14Not applicableUS flag
MenactraNeisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen (4 mcg/mL) + Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen (4 mcg/mL) + Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen (4 mcg/mL) + Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen (4 mcg/mL)SolutionIntramuscularSanofi Pasteur Limited2006-10-20Not applicableCanada flag
MenactraNeisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen (4 ug/0.5mL) + Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen (4 ug/0.5mL) + Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen (4 ug/0.5mL) + Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen (4 ug/0.5mL)Injection, solutionIntramuscularRemedy Repack2015-01-032016-03-29US flag
MENACTRANeisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen (4 mcg/0.5ml) + Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen (4 mcg/0.5ml) + Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen (4 mcg/0.5ml) + Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen (4 mcg/0.5ml)SolutionIntramuscularบริษัท ซาโนฟี่ ปาสเตอร์ จำกัด2015-02-17Not applicableThailand flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
MI340WV90B
CAS number
Not Available

References

General References
Not Available
PubChem Substance
347910906
RxNav
797635
FDA label
Download (281 KB)

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4Active Not RecruitingPreventionMeningococcal Disease, Invasive1
4CompletedPreventionAcellular Pertussis / Diphtheria / Tetanus1
4CompletedPreventionDiphtheria / Haemophilus Influenzae Serotype b (Hib) / Meningitis / Meningococcal Infections / Pertussis / Tetanus1
4CompletedPreventionFlu caused by Influenza1
4CompletedPreventionMeningitis1
4CompletedPreventionMeningitis / Meningococcal Infections / Meningococcal Meningitis1
4Not Yet RecruitingPreventionPreventive Immunization; Meningitis1
3CompletedPreventionDiphtheria / Meningitis / Neoplasms, Glandular and Epithelial / Tetanus / Whooping Cough1
3CompletedPreventionHuman Papillomavirus Infections1
3CompletedPreventionMeningococcal Infections1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, solutionIntramuscular
SolutionIntramuscular
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at December 01, 2015 20:04 / Updated at June 12, 2020 16:53